1. Backus, K. H., Arigoni, M., Drescher, U., Scheurer, L., Malherbe, P., Möhler, H., and Benson, J. A. (1993). Stoichiometry of a recombinant GABAA receptor deduced from mutation-induced rectification.NeuroReport 5285–288.
2. Barker, J. L., Harrison, N. L., Lange, G. D., and Owen, D. G. (1987). Potentiation of γ-aminobutyric-acid-activated chloride conductance by a steroid anaesthetic in cultured rat spinal neurones.J. Physiol. 386485–501.
3. Belelli, D., Lambert, J. J., Peters, J. A., Lan, N. C., and Gee, K. W. (1994a). Modulation of mammalian GABAA receptors by the neurosteroid 5α-pregnan-3α,20α-diol.Br. J. Pharmacol. 111:182P.
4. Belelli, D., Lambert, J. J., Peters, J. A., Lan, N. C., and Gee, K. W. (1994b). Modulation of human (α1β1γ2L) recombinant GABAA receptors by pregnanediols.Can. J. Physiol. Pharmacol. 72339.
5. Belelli, D., Callachan, H., Lambert, J. Peters, J. A., Hill-Venning, C., and Lan, N. C. (1994c). A comparative study of the influence of allosteric modulators upon human (α3β1γ2L) andDrosophila recombinant GABA receptors.Br. J. Pharmacol. 112:257P.